Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG)
K-Number: K213652 · 2023-06-28
Device Summary
Frequently Asked Questions
What is the Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG)?
Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG) is a medical device that received FDA 510(k) clearance on 2023-06-28. The listed applicant is Cresilon, Inc.. The 510(k) number is K213652.
When did Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG) receive FDA 510(k) clearance?
Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG) received FDA 510(k) clearance on 2023-06-28, under 510(k) number K213652.
Who is the listed applicant for Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG)?
The FDA 510(k) record lists Cresilon, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG)?
The FDA product code for Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG) is QSY.
Other records listing Cresilon, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: QSY)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.